Outset Medical, Inc. (OM)

NASDAQ • Currency in USD

$14.15

+$0.61

+4.51%

Last Update: 11 Sept 2025, 20:00

$251.39M

Market Cap

-2.47

P/E Ratio (TTM)

—

Forward Dividend Yield

$5.85 - $25.35

52 Week Range

OM Stock Price Chart

Explore Outset Medical, Inc. interactive price chart. Choose custom timeframes to analyze OM price movements and trends.

OM Company Profile

Discover essential business fundamentals and corporate details for Outset Medical, Inc. (OM) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

15 Sept 2020

Employees

354.00

Website

https://www.outsetmedical.com

CEO

Leslie L. Trigg

Description

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

OM Financial Timeline

Browse a chronological timeline of Outset Medical, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 5 May 2026

Upcoming earnings on 5 Jan 2026

Upcoming earnings on 5 Nov 2025

EPS estimate is -$0.64, while revenue estimate is $30.69M.

Earnings released on 6 Aug 2025

EPS came in at -$0.84 surpassing the estimated -$1.76 by +52.27%, while revenue for the quarter reached $31.42M , beating expectations by +6.84%.

Earnings released on 7 May 2025

EPS came in at -$3.24 falling short of the estimated -$0.97 by -234.02%, while revenue for the quarter reached $29.75M , beating expectations by +6.98%.

Stock split effective on 20 Mar 2025

Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 19 Feb 2025

EPS came in at -$5.55 surpassing the estimated -$6.45 by +13.95%, while revenue for the quarter reached $29.47M , beating expectations by +3.49%.

Earnings released on 6 Nov 2024

EPS came in at -$5.85 surpassing the estimated -$6.30 by +7.14%, while revenue for the quarter reached $28.67M , beating expectations by +6.57%.

Earnings released on 7 Aug 2024

EPS came in at -$7.05 falling short of the estimated -$6.45 by -9.30%, while revenue for the quarter reached $27.39M , missing expectations by -12.19%.

Earnings released on 8 May 2024

EPS came in at -$8.55 falling short of the estimated -$7.95 by -7.55%, while revenue for the quarter reached $28.17M , missing expectations by -7.16%.

Earnings released on 21 Feb 2024

EPS came in at -$8.85 surpassing the estimated -$9.15 by +3.28%, while revenue for the quarter reached $30.51M , beating expectations by +0.35%.

Earnings released on 7 Nov 2023

EPS came in at -$10.64 falling short of the estimated -$9.90 by -7.47%, while revenue for the quarter reached $30.36M , missing expectations by -0.09%.

Earnings released on 2 Aug 2023

EPS came in at -$10.34 surpassing the estimated -$10.94 by +5.48%, while revenue for the quarter reached $36.04M , missing expectations by -4.05%.

Earnings released on 3 May 2023

EPS came in at -$10.79 falling short of the estimated -$10.34 by -4.35%, while revenue for the quarter reached $33.47M , beating expectations by +5.37%.

Earnings released on 13 Feb 2023

EPS came in at -$10.64 surpassing the estimated -$11.39 by +6.58%, while revenue for the quarter reached $32.01M , beating expectations by +3.52%.

Earnings released on 8 Nov 2022

EPS came in at -$10.49 surpassing the estimated -$10.64 by +1.41%, while revenue for the quarter reached $27.76M , beating expectations by +10.07%.

Earnings released on 1 Aug 2022

EPS came in at -$11.54 falling short of the estimated -$9.45 by -22.12%, while revenue for the quarter reached $25.06M , missing expectations by -8.87%.

Earnings released on 4 May 2022

EPS came in at -$10.04 falling short of the estimated -$9.90 by -1.41%, while revenue for the quarter reached $30.55M , beating expectations by +1.48%.

Earnings released on 16 Feb 2022

EPS came in at -$11.54 falling short of the estimated -$10.04 by -14.94%, while revenue for the quarter reached $28.15M , beating expectations by +6.53%.